BEAM - Latest News
Beam Therapeutics Inc. (BEAM), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $2.75B. Beta to the broader market is 2.21.
The article list below shows the most recent BEAM headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BEAM Headlines
BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus
zacks.com - Aug 5, 2026
Beam Therapeutics posts a wider-than-expected Q2 loss. Revenues also miss estimates as it advances multiple genome-editing programs with key clinical
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - Aug 4, 2026
Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1.
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
globenewswire.com - Aug 4, 2026
Updated BEAM-302 Phase 1/2 Clinical Data Selected for Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026
Beam Therapeutics: A Valuation With Upside Left
seekingalpha.com - Aug 3, 2026
Beam Therapeutics offers compelling upside, with a $2. 64B market cap and a promising gene-editing pipeline spanning hematology and liver-targeted dis
Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026
globenewswire.com - Jul 23, 2026
CAMBRIDGE, Mass. , July 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc.
How News Affects BEAM Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BEAM's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BEAM news questions
- What is the latest BEAM news headline?
- The most recent BEAM headline (Aug 5, 2026) is "BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BEAM news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BEAM news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BEAM options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.